Do sarcoidosis drugs raise cancer risk? new study investigates
NCT ID NCT07343401
Summary
This study aimed to understand if the medications used to treat sarcoidosis, an inflammatory lung disease, affect a patient's risk of developing lymphoma, a type of blood cancer. Researchers followed 40 adults with sarcoidosis for one year while they were on their standard treatment. The goal was to gather information to help doctors better understand the long-term safety of these common therapies.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SARCOIDOSIS LUNG are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Alexandria main university hospital
Alexandria, Asafra, 11511, Egypt
Conditions
Explore the condition pages connected to this study.